celecoxib has been researched along with Coronary Thrombosis in 4 studies
Coronary Thrombosis: Coagulation of blood in any of the CORONARY VESSELS. The presence of a blood clot (THROMBUS) often leads to MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cyclovirobuxine D is an active compound extracted from Buxus microphylla, which has been used for treating acute myocardial ischemia in China." | 7.74 | Cyclovirobuxine D ameliorates acute myocardial ischemia by K(ATP) channel opening, nitric oxide release and anti-thrombosis. ( Chen, S; Hu, D; Liu, X; Wang, Y, 2007) |
| "Cyclovirobuxine D is an active compound extracted from Buxus microphylla, which has been used for treating acute myocardial ischemia in China." | 3.74 | Cyclovirobuxine D ameliorates acute myocardial ischemia by K(ATP) channel opening, nitric oxide release and anti-thrombosis. ( Chen, S; Hu, D; Liu, X; Wang, Y, 2007) |
| "In celecoxib-treated animals, vasodilation in response to arachidonic acid was reduced significantly compared with controls." | 1.31 | Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries. ( Barrett, TD; Crofford, LJ; Driscoll, EM; Hennan, JK; Huang, J; Lucchesi, BR; Park, AM; Willens, DE, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strand, V | 1 |
| Hochberg, MC | 1 |
| Hu, D | 1 |
| Liu, X | 1 |
| Wang, Y | 1 |
| Chen, S | 1 |
| Hennan, JK | 1 |
| Huang, J | 1 |
| Barrett, TD | 1 |
| Driscoll, EM | 1 |
| Willens, DE | 1 |
| Park, AM | 1 |
| Crofford, LJ | 1 |
| Lucchesi, BR | 1 |
| White, WB | 1 |
| Faich, G | 1 |
| Whelton, A | 1 |
| Maurath, C | 1 |
| Ridge, NJ | 1 |
| Verburg, KM | 1 |
| Geis, GS | 1 |
| Lefkowith, JB | 1 |
1 review available for celecoxib and Coronary Thrombosis
| Article | Year |
|---|---|
The risk of cardiovascular thrombotic events with selective cyclooxygenase-2 inhibitors.
Topics: Aged; Celecoxib; Coronary Thrombosis; Cyclooxygenase Inhibitors; Female; Humans; Lactones; Male; Pyr | 2002 |
1 trial available for celecoxib and Coronary Thrombosis
| Article | Year |
|---|---|
Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular System; Celecoxib; Coronary Thrombosi | 2002 |
2 other studies available for celecoxib and Coronary Thrombosis
| Article | Year |
|---|---|
Cyclovirobuxine D ameliorates acute myocardial ischemia by K(ATP) channel opening, nitric oxide release and anti-thrombosis.
Topics: Acute Disease; Animals; Animals, Newborn; Celecoxib; Cell Hypoxia; Cell Survival; Cells, Cultured; C | 2007 |
Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries.
Topics: Acetylcholine; Animals; Arachidonic Acid; Aspirin; Benzofurans; Blood Flow Velocity; Celecoxib; Coro | 2001 |